| Hans-Günter Meyer-Thompson | Hepatitiden
Impact of hepatitis C serostatus on health service utilization for opioid-related harms among individuals prescribed opioid agonist therapy: A longitudinal prospective cohort study.
Impact of hepatitis C serostatus on health service utilization for opioid-related harms among individuals prescribed opioid agonist therapy: A longitudinal prospective cohort study.
Guyatt P, Babe G, Gayowsky A, Rosic T, Rodrigues M, Bach P, Perez R, de Oliveira C, Samet JH, Kerkerian G, Hann J, Dionne JC, Ahmed A, Kim D, Nolan S, Thabane L, Samaan Z, Dennis BB.
Drug Alcohol Depend Rep. 2025 Jul 29;16:100368. doi: 10.1016/j.dadr.2025.100368. PMID: 40837618; PMCID: PMC12361781.